Oncolytics Biotech Inc. (ONCY)
NASDAQ: ONCY · Real-Time Price · USD
0.7600
-0.0321 (-4.05%)
Jul 29, 2026, 10:15 AM EDT - Market open
Oncolytics Biotech Employees
Oncolytics Biotech had 29 employees as of December 31, 2025. The number of employees increased by 1 or 3.57% compared to the previous year.
Employees
29
Change (1Y)
1
Growth (1Y)
3.57%
Revenue / Employee
n/a
Profits / Employee
-$1,147,966
Market Cap
90.71M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 29 | 1 | 3.57% |
| Dec 31, 2024 | 28 | -1 | -3.45% |
| Dec 31, 2022 | 29 | 3 | 11.54% |
| Dec 31, 2021 | 26 | 1 | 4.00% |
| Dec 31, 2020 | 25 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Pelthos Therapeutics | 92 |
| ImmuCell | 73 |
| Rani Therapeutics Holdings | 71 |
| Biomea Fusion | 40 |
| Entera Bio | 22 |
| Black Diamond Therapeutics | 21 |
| Coya Therapeutics | 8 |
| Aldeyra Therapeutics | 7 |
ONCY News
- 9 days ago - Oncolytics announces FDA Fast Track designation for pelareorep - TheFly
- 9 days ago - Oncolytics Biotech® Receives Fast Track Designation for Pelareorep in Second-Line and Later Anal Cancer - GlobeNewsWire
- 16 days ago - Oncolytics provides clinical, regulatory update on REO 033 - TheFly
- 16 days ago - Oncolytics Biotech® Reports FDA Regulatory Milestone and Strong Clinical Progress in Randomized RAS-Mutant MSS Colorectal Cancer Trial - GlobeNewsWire
- 6 weeks ago - Oncolytics secures new patent for pelareorep manufacturing - TheFly
- 6 weeks ago - Oncolytics Biotech® Secures New U.S. Patent Protecting Commercial Manufacturing of Pelareorep into 2044 - GlobeNewsWire
- 7 weeks ago - Oncolytics Biotech Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 2 months ago - Oncolytics promotes John McAdory to COO - TheFly